Frequency of Type 2 Diabetes Mellitus among Patients with Hepatitis C Virus Infection
Article Sidebar
Main Article Content
Abstract
Background: Hepatitis C virus (HCV) infection and type 2 diabetes mellitus (T2DM) have established themselves as significant global health concerns, with a notable co-prevalence that suggests a potential pathophysiological connection. The increasing incidence of T2DM, particularly in developing countries, alongside the significant burden of HCV, poses challenges for healthcare systems and necessitates deeper understanding of their interrelation.
Objective: This study aimed to ascertain the frequency of T2DM among patients with HCV infection and to investigate the potential association between HCV reactivity and the incidence of T2DM.
Methods: A cross-sectional analysis was conducted at a molecular pathology laboratory in Lahore, Pakistan. Patients aged 18-60 years without cirrhosis or pre-existing T2DM were consecutively enrolled over a six-month period. Exclusion criteria included liver cancer, interferon therapy, end-stage renal disease, other viral hepatitides, and pregnancy. Data were collected via questionnaires after informed consent, with serum and hemoglobin A1c (HbA1c) levels measured. HCV reactivity was confirmed via real-time polymerase chain reaction (RT-PCR), and the frequency of T2DM was assessed by HbA1c criteria. Statistical analysis involved univariate analysis using SPSS version 25.0.
Results: Among the 300 HCV-reactive patients, the frequency of T2DM was found to be 49.33% (148 patients). The mean age of participants was 42.71 ± 6.808 years, with 53.0% males and 47.0% females. Urban and rural participants were nearly equally represented. A significant association was noted between HCV reactivity and T2DM (p=0.001), while no significant relationship was found with gender, residence, marital status, or family history of T2DM.
Conclusion: The study highlights a substantial frequency of T2DM in HCV-reactive patients and a significant association between HCV infection and the development of T2DM. Regular HbA1c monitoring in HCV-reactive patients is recommended for the early identification and management of T2DM.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Safi SZ, Shah H, Imran M, Noreen M, Latif Z, Rehman F, et al. Association of type 2 diabetes and hepatitis C virus infection in Pakistani population: A meta-analysis. Songklanakarin Journal of Science & Technology. 2022;44(5):1193-200.
Ullah N, Kakakhel M, Bai Y, Xi L, Khan I, Kalra B, et al. Prevalence of active HCV infection and genotypic distribution among the general population of district Mardan, Pakistan. Brazilian Journal of Biology. 2021;83.
Adnan M, Aasim M. Prevalence of type 2 diabetes mellitus in the adult population of Pakistan: a meta-analysis of prospective cross-sectional surveys. Annals of global health. 2020;86(1).
Talib F. Incidence of Diabetes Mellitus in Patients Having Chronic Hepatitis B &C. Sch Int J Anat Physiol. 2021;4(11):183-90.
Chen Y, Ji H, Shao J, Jia Y, Bao Q, Zhu J, et al. Different hepatitis C virus infection statuses show a significant risk of developing type 2 diabetes mellitus: a network meta-analysis. Digestive Diseases and Sciences. 2020;65:1940-50.
Jeong D, Karim ME, Wong S, Wilton J, Butt ZA, Binka M, et al. Impact of HCV infection and ethnicity on incident type 2 diabetes: findings from a large population-based cohort in British Columbia. BMJ Open Diabetes Research and Care. 2021;9(1):e002145.
Ciardullo S, Mantovani A, Ciaccio A, Carbone M, Invernizzi P, Perseghin G. Hepatitis C virus infection and diabetes: A complex bidirectional relationship. Diabetes Research and Clinical Practice. 2022;187:109870.
Tanwar S, Rhodes F, Srivastava A, Trembling PM, Rosenberg WM. Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C. World journal of gastroenterology. 2020;26(2):109.
Chaudhari R, Fouda S, Sainu A, Pappachan JM. Metabolic complications of hepatitis C virus infection. World journal of gastroenterology. 2021;27(13):1267.
Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomarker insights. 2016;11:BMI. S38440.
Merza MA. Seroprevalence and risk factors of hepatitis B and C viruses among diabetes mellitus patients in Duhok province, Iraqi Kurdistan. Journal of Family Medicine and Primary Care. 2020;9(2):642.
Kadla SA, Shah NA, Pathania R, Khan BA, Mir SA, Shah AI, et al. prevalence of diabetes mellitus in newly detected patients with hepatitis C. Journal of Diabetology. 2020;11(2):101-8.
Allison ME, Wreghitt T, Palmer CR, Alexander GJ. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. Journal of hepatology. 1994;21(6):1135-9.
Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Annals of internal medicine. 2000;133(8):592-9.
Qureshi H, Ahsan T, Mujeeb S, Jawad F, Mehdi I, Ahmed W, et al. Diabetes mellitus is equally frequent in chronic HCV and HBV infection. JPMA The Journal of the Pakistan Medical Association. 2002;52(7):280-3.
Siddiqui M, Kamani L, Rahat A. FREQUENCY AND ASSOCIATED FACTORS OF INSULIN RESISTANCE AMONG NON-DIABETIC PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE USING HOMA-IR: AN EXPERIENCE OF A TERTIARY CARE HOSPITAL IN KARACHI.
Elhawary EI, Mahmoud GF, El-Daly MA, Mekky FA, Esmat GG, Abdel-Hamid M. Association of HCV with diabetes mellitus: an Egyptian case-control study. Virology Journal. 2011;8(1):1-9.
Shera AS, Basit A, Fawwad A, Hakeem R, Ahmedani MY, Hydrie MZI, et al. Pakistan National Diabetes Survey: prevalence of glucose intolerance and associated factors in the Punjab Province of Pakistan. Primary care diabetes. 2010;4(2):79-83.
Chiquete E, Ochoa-Guzmán A, García-Lamas L, Anaya-Gómez F, Gutiérrez-Manjarrez JI, Sánchez-Orozco LV, et al. Hepatitis C virus infection and type 2 diabetes mellitus in Mexican patients. Revista Médica del Instituto Mexicano del Seguro Social. 2012;50(5):481-6.
Arain ZI. Prevalence of type 2 diabetes mellitus in hepatitis C virus infected population: A Southeast Asian study. 2014.
Kalar MU, Ali AAM, Ali S, Hasan SMU, Kazmi SJZ, Hasan HZ, et al. Frequency of diabetes in hepatitis. International Journal of Collaborative Research on Internal Medicine & Public Health. 2014;6(7):226.
Villar LM, Geloneze B, Vasques ACJ, Pires MLE, Miguel JC, da Silva EF, et al. Prevalence of hepatitis B and hepatitis C among diabetes mellitus type 2 individuals. PloS one. 2019;14(2):e0211193.
García-Compeán D, Orsi E, Kumar R, Gundling F, Nishida T, Villarreal-Pérez JZ, et al. Clinical implications of diabetes in chronic liver disease: Diagnosis, outcomes and management, current and future perspectives. World Journal of Gastroenterology. 2022;28(8):775.
Hum J, Jou JH. The link between hepatitis C virus and diabetes mellitus: Improvement in insulin resistance after eradication of hepatitis C virus. Clinical liver disease. 2018;11(3):73.
Zajkowska M, Mroczko B. Chemokines in primary liver cancer. International Journal of Molecular Sciences. 2022;23(16):8846.